New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg ...
First-in-human healthy volunteers trial showed SYX-5219 was safe and well toleratedSystemic immunomodulation of type 2 inflammation demonstrated ...
Corvus Pharmaceuticals (CRVS) lost ~13% on Thursday after the biotech posted final data from a Phase 1 trial for its lead ...
Hosted on MSN
Atopic Dermatitis vs. Eczema: Is There a Difference?
Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar. These chronic (meaning they can last a long time) inflammatory conditions can appear ...
Credit: Getty Images. Clinical phenotypes of atopic dermatitis can vary greatly based on skin color and can make atopic dermatitis difficult to diagnose. Recognizing the clinical diversity of ...
Atopic dermatitis is a chronic inflammatory skin disease that causes extreme dryness, itchy rashes, scaly patches, and blisters that can ooze, crust, and flake. It affects people of all ages, all over ...
There’s no single test that can diagnose atopic dermatitis (the most common type of eczema). Rather, diagnosing this skin condition requires a careful, multifaceted investigation of signs and symptoms ...
Experts break down the most important facts about atopic dermatitis on the hands, including risk factors, treatments, and tips for soothing relief. Atopic dermatitis (AD), the most common form of ...
Bambusa expects to announce top line results from the four-week treatment study by the middle of 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results